[Drug treatment of sleep disorders].
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001143:Arousal / Q000187:drug effects; D001569:Benzodiazepines; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000097:blood / Q000627:therapeutic use*; D008657:Metabolic Clearance Rate; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D012894:Sleep Stages / Q000187:drug effects
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D006633:Histamine Antagonists; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines
Medikamentöse Behandlung von Schlafstörungen.